Multinuclear MRI in Drug Discovery

Molecules. 2022 Oct 1;27(19):6493. doi: 10.3390/molecules27196493.

Abstract

The continuous development of magnetic resonance imaging broadens the range of applications to newer areas. Using MRI, we can not only visualize, but also track pharmaceutical substances and labeled cells in both in vivo and in vitro tests. 1H is widely used in the MRI method, which is determined by its high content in the human body. The potential of the MRI method makes it an excellent tool for imaging the morphology of the examined objects, and also enables registration of changes at the level of metabolism. There are several reports in the scientific publications on the use of clinical MRI for in vitro tracking. The use of multinuclear MRI has great potential for scientific research and clinical studies. Tuning MRI scanners to the Larmor frequency of a given nucleus, allows imaging without tissue background. Heavy nuclei are components of both drugs and contrast agents and molecular complexes. The implementation of hyperpolarization techniques allows for better MRI sensitivity. The aim of this review is to present the use of multinuclear MRI for investigations in drug delivery.

Keywords: MRI; drug cell culture tissue; tracking.

Publication types

  • Review

MeSH terms

  • Contrast Media*
  • Drug Discovery
  • Humans
  • Magnetic Resonance Imaging* / methods
  • Pharmaceutical Preparations

Substances

  • Contrast Media
  • Pharmaceutical Preparations

Grants and funding

This research received no external funding.